Monitoring Access to Child Medicines
Introducing a Standardized Set of Age-Appropriate Medicines
Bibliographic Data
| ID | 15713232 |
|---|---|
| Authors | Iris R Joosse (0000-0001-7677-8589, Utrecht University), Aukje K Mantel‐teeuwisse (0000-0002-8782-0698, Utrecht University), Fátima Suleman (0000-0002-5963-2892, University of KwaZulu-Natal), Hendrika A van den Ham (0000-0003-1339-9818, Utrecht University, corresponding author) |
| Year | 2024 |
| Volume | 11 |
| Issue | 3 |
| Pages | 266-266 |
| Publication date | 2024-02-20 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Children (JOURNAL) |
| Journal identifiers | ISSN: 2227-9067 • E-ISSN: 2227-9067 |
| Publisher | Multidisciplinary Digital Publishing Institute (PUBLISHER • CH) |
| DOI | 10.3390/children11030266 |
| PMID | 38539301 |
| OpenAlex | W4391979892 |
| Language | EN |
| References cited | 16 |
Monitoring access to pediatric medicines as part of the Sustainable Development Goal (SDG) agenda for 2030 requires surveying age-appropriate medicines. This study aimed to develop tracer sets of essential age-appropriate medicines for use in SDG indicator 3.b.3 or in conjunction with other methodologies for monitoring access to medicines. Two sets of medicines were developed, one for young children (1 month to 5 years) and one for school-aged children (5-12 years). Priority diseases were selected based on the global burden of disease and linked to active ingredients of first choice according to treatment guidelines and the World Health Organization (WHO) Model List of Essential Medicines for Children (EMLc). To ensure clinical relevance, the Delphi technique was employed to identify areas of (dis)agreement among clinical pediatric experts. During two consultation rounds, experts were invited to indicate (dis)agreement. Five experts per age group were largely in agreement with the initial selections, but various therapeutic alternatives were suggested for addition. A second consultation round with five experts did not lead to major adjustments. The final sets included 26 treatment options for both groups. Specific age-appropriate formulations were selected from the WHO EMLc 2023. These two globally representative tracer sets of medicines consider the particular needs of children and could aid countries in the critical monitoring of accessibility to pediatric medicines
Access to medicines · Age groups · Delphi · Delphi method · Environmental health · Essential medicines · Family medicine · Political science · Public health · Relevance (law · Adolescent and Pediatric Healthcare · Child and Adolescent Health · Computer Science · Demography · Medicine · Nursing · Pharmaceutical studies and practices · Pediatrics
| Citation velocity | historical |
|---|---|
| Highly cited | No |